Vimarsana
Biggest News Aggregation in the World

Dan Cua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Cua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Cua Today - Breaking & Trending Today

TREMFYA® (guselkumab) Demonstrates a Differentiated Binding Mechanism from Risankizumab in In Vitro Studies - Vimarsana News

TREMFYA® (guselkumab) Demonstrates a Differentiated Binding Mechanism from Risankizumab in In Vitro Studies

Published: March 3, 2023

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced additional results from in vitro MODIF-Y studies, which continue to...

Source: prnewswire.com
Related Topics:
Spring HouseBritish ColumbiaCraig StoltzDan CuaRaja AtreyaErlangen University HospitalNone Of The Janssen Pharmaceutical CompaniesColitis OrganizationCenters For DiseaseNational Institutes Of HealthSociety For Investigative DermatologyJanssen Research DevelopmentJanssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonExchange CommissionCompanies Of JohnsonClinical Study CentreEuropean CrohnSenior PhysicianInflammatory Bowel Disease UnitOutpatient ClinicVice PresidentJanssen ResearchBowel DiseasePrescribing Information
New Data Show TREMFYA® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab - Vimarsana News

New Data Show TREMFYA® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab

Published: May 18, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesUnited KingdomRockefeller UniversitySpring HouseBritish ColumbiaJamesg KruegerScandj RheumatolD Martin CarterDonvitot CreakyjointsDan CuaBridget KimmelZismand ComorbiditiesNone Of The Janssen Pharmaceutical CompaniesDrug AdministrationSociety For Investigative DermatologyJanssen Research DevelopmentJanssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonResearch DevelopmentExchange CommissionCompanies Of JohnsonNational Psoriasis FoundationJournal Of The American Academy DermatologyInvestigative Dermatology